Market Access Navigating NHS procurement processes: What start-ups need to... The NHS finds itself in a very challenging place post-COVID, with unprecedented waiting lists, stretched finances, and a staffing crisis.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.